Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: Exacctnt who wrote (1996)	7/13/1998 9:45:00 PM
From: Machaon	Read Replies (1) \| Respond to of 2553

I was hoping that you had cashed in around $5, but it was a great call, on your part. I wish I had listened! It'll be interesting to see what happens to both Atis and GENZL tomorrow. It seems like skin growing is becoming a hot issue, in the news lately! My biotech holdings have been going nuts lately. Up a bunch one day, down a bunch the next, etc. To me, it's a good sign that things are starting to heat up in the Biotech sector. According to articles, the biotech sector has been hit by short term traders most of this year. A few more blockbusters, such as ENMD, might turn a lot of traders into long term holders. $70 per share, in one day, ain't a bad return, but you have to be "in" the stock to get it. GENZL's Earnings Report will be out a week from this Wednesday. It sure would be nice to have some kickass earnings, for a change! Good luck, Bob